Columbia Care has a total of 33 patents globally, out of which no patent has been granted. Of these 33 patents, more than 60% patents are active. United States Of America is where Columbia Care has filed the maximum number of patents, followed by Europe and Canada. Parallelly, United States Of America seems to be the main focused R&D centre of Columbia Care.
Columbia Care was founded in the year 2012. Company is a patient-center healthcare company setting the standard of care for medical marijuana.
Do read about some of the most popular patents of Columbia Care which have been covered by us in this article and also you can find Columbia Care patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Columbia Care patent portfolio.
How many patents does Columbia Care have?
Columbia Care has a total of 33 patents globally. These patents belong to 9 unique patent families. Out of 33 patents, 20 patents are active.
How Many Patents did Columbia Care File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
| Year of Patents Filing or Grant | Columbia Care Applications Filed | Columbia Care Patents Granted |
| 2021 | 1 | – |
| 2020 | 9 | – |
| 2019 | 16 | – |
| 2017 | 7 | – |
How many Columbia Care patents are Alive/Dead?
How Many Patents did Columbia Care File in Different Countries?
Where are Research Centres of Columbia Care Patents Located?
All Research Centres of Columbia Care Patents are located in United States Of America.
List of Columbia Care Patents
| Columbia Care Patents | Title |
| EP3908352A4 | Inhalable dosage form of cannabinoid extract |
| EP3908275A4 | Rapidly disintegrating oral tablet |
| EP3906025A4 | Topical formulations having cannabinoid |
| EP3876903A4 | Stabilized terpiene-enriched cannabinoid extract and methods of use thereof |
| EP3876925A4 | Sublingual and buccal dosage forms of cannabinoid extracts and method of use thereof |
| EP3876907A4 | Suppository formulations having cannabinoid |
| US20220105070A1 | Topical formulations having cannabinoid |
| US20220062170A1 | Inhalable dosage form of cannabinoid extract |
| US20220023220A1 | Rapidly disintegrating oral tablet |
| US20220000763A1 | Sublingual and buccal dosage forms of cannabinoid extracts and method of use thereof |
| US20220000774A1 | Suppository formulations having cannabinoid |
| US20220000764A1 | Stabilized terpene-enriched cannabinoid extract and methods of use thereof |
| US20210378967A1 | Hard-pressed scored splittable marijuana tablets |
| WO2021173755A1 | Child-proof balm stick |
| EP3755309A1 | Hard-pressed scored splittable marijuana tablets |
| JP2019530717A5 | Oral compositions of extracted cannabinoids and methods of their use |
| WO2020146383A1 | Inhalable dosage form of cannabinoid extract |
| WO2020146753A1 | Rapidly disintegrating oral tablet |
| WO2020142692A1 | Topical formulations having cannabinoid |
| US20200163931A1 | Oral composition of extracted cannabinoids and methods of use thereof |
| WO2020097187A1 | Stabilized terpine-enriched cannabinoid extract and methods of use thereof |
| WO2020097362A1 | Sublingual and buccal dosage forms of cannabinoid extracts and method of use thereof |
| WO2020097358A1 | Suppository formulations having cannabinoid |
| CA3118893A1 | Stabilized terpine-enriched cannabinoid extract and methods of use thereof |
| CA3118895A1 | Suppository formulations having cannabinoid |
| CA3118898A1 | Sublingual and buccal dosage forms of cannabinoid extracts and method of use thereof |
| EP3525764A4 | An oral composition of extracted cannabinoids and methods of use thereof |
| WO2019165117A1 | Hard-pressed scored splittable marijuana tablets |
| CA3092060A1 | Hard-pressed scored splittable marijuana tablets |
| BR112019006463A2 | ORAL COMPOSITION OF EXTRACTED CANABINOIDS AND METHODS OF USE THEREOF |
| AU2017341707A1 | An oral composition of extracted cannabinoids and methods of use thereof |
| WO2018071581A1 | An oral composition of extracted cannabinoids and methods of use thereof |
| CA3038541A1 | An oral composition of extracted cannabinoids and methods of use thereof |